HPS Pharmacies wish to advise that Novartis Pharmaceuticals Australia Pty Ltd, in consultation with the Therapeutic Goods Administration (TGA), have given notice of a drug recall of:
Lescol® 20mg Tablets
ARTG 50268 (cancelled)
The only affected batch is B2014 with an expiry date of September 2017.
This recall has been initiated due to a manufacturing issue that has affected the stability of the product. The result is the presence of degradation products in excess of the currently approved limits. This is not expected to pose any risk to patient safety.
Please inspect your stocks and quarantine all products from the batch stated above for return to your supplier for a refund. No replacement stock can be arranged as this is a discontinued product.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Novartis on 1800 064 713.
Information regarding expected dates for supply may vary subject to delays which are out of our control. HPS Pharmacies does not accept responsibility for such changes but will endeavour to keep our clients updated as information is made available from drug manufacturers or wholesalers.